Clinical results with omni-orthocor,(r) an implantable antitachycardia pacing system.
Omni-Orthocor 234A and 239A are implantable pacers capable of synchronization with an external overdriver, Synchronous or asynchronous burst pacing, synchronized extrastimuli, or a combination of both can be obtained. Upon recognition of a tachycardia, the patient or physician can initiate pace-term...
| Publicado en: | Pacing & Clinical Electrophysiology Vol. 7; no. 6; pp. 1306 - 1313 |
|---|---|
| Autores principales: | , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
Nov1984
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106034824&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106034824 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01478389 4F8 jtl: Pacing & Clinical Electrophysiology issn: 01478389 maglogo: Y pubinfo: dt: Nov1984 vid: 7 iid: 6 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 106034824 2009408002 NLM6209675 106034824 ppf: 1306 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Clinical results with omni-orthocor,(r) an implantable antitachycardia pacing system. aug: au: Rothman MT Keefe JM sug: ab: Omni-Orthocor 234A and 239A are implantable pacers capable of synchronization with an external overdriver, Synchronous or asynchronous burst pacing, synchronized extrastimuli, or a combination of both can be obtained. Upon recognition of a tachycardia, the patient or physician can initiate pace-termination. Omni-Orthocor was implanted in 69 patients [53 for ventricular tachycardia, 11 for supraventricular tachycardia, 2 each with AV nodal reentry and WPW, and 1 patient with concealed accessory pathway). Thirty-five patients performed out of hospital termination. More resistant tachycardias were terminated in the hospital with 76.3% success in VT and only 50% success for SVT. Burst pacing was used in 75% of patients. Noninvasive electrophysiologie study was performed on all patients, and was the sole use of Omni-Orthocor in 20 patients. The device was not implicated in the six sudden death patients in this series. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|